|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/454 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3490560 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17754226.3 |
| Date of filing the European patent application | 2017-07-28 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-22 |
| (46) | Date of publication of the claims translation | 2025-02-25 |
| (86) | Number | PCT/US2017/044413 |
| Date | 2017-07-28 |
| (87) | Number | WO 2018/023017 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201662368466 P | 2016-07-29 | US | |
| 201662369239 P | 2016-08-01 | US |
| (72) |
GOTTARDIS, Marco , US
HAWKINS, Rebecca , PA
SNYDER, Linda , US
YAMADA, Douglas H. , US
|
| (73) |
Janssen Pharmaceutica, N.V. ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdas prostatos vėžiui gydyti naudojant niraparibą |
| NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| 2026-07-28 |